Brutal, IMS (RX) shares are selling off 25% to $21.80, a 52-week low Bad earnings followed by downgrades. IMS Health which is a provider of market intelligence to the pharmaceutical and healthcare ...

Global prescription sales growth of generics drugs slowed to 3.6 percent in the twelve months ending September 2008, down from 11.4 percent in 2007, a ...

US prescription drug sales grew 5.4% to $251.8 billion in 2005, compared with $238.9 billion in sales the previous year, according to healthcare information firm IMS Health.

PARSIPPANY, N.J. — U.S. spending on drugs grew 2.3% to $307.4 billion in 2010, according to a new report by the IMS Institute for Healthcare Informatics, part of industry research firm IMS Health.

The UK Competition Commission has provisionally decided not to remove or vary current restrictions on how IMS Health sells its specialised pharmaceutical data services.